Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

被引:203
|
作者
Rosenson, Robert S. [1 ]
Davidson, Michael H. [2 ]
Hirsh, Benjamin J. [3 ]
Kathiresan, Sekar [4 ]
Gaudet, Daniel [5 ,6 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Univ Chicago, Pritzker Sch Med, Div Cardiol, Chicago, IL 60637 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[5] Univ Montreal, Dept Med, ECOGENE 21, Chicoutimi, PQ, Canada
[6] Univ Montreal, Dept Med, Lipid Clin, Chicoutimi, PQ, Canada
关键词
atherosclerosis; cardiovascular disease; genetics; triglyceride; triglyceride-rich lipoproteins; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; APOLIPOPROTEIN C-III; ALIPOGENE TIPARVOVEC AAV1-LPLS447X; TISSUE-SPECIFIC EXPRESSION; CYTOSOLIC LIPID DROPLETS; GENOME-WIDE ASSOCIATION; EXTENDED-RELEASE NIACIN; NONFASTING TRIGLYCERIDES; SEVERE HYPERTRIGLYCERIDEMIA;
D O I
10.1016/j.jacc.2014.09.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease (CVD) risk biomarkers prompted investigations into therapies that lower plasma triglycerides as a means to reduce CVD events. Genetic studies identified TGRL components and pathways involved in their synthesis and metabolism. We advocate that only a subset of genetic mechanisms regulating TGRLs contribute to the risk of CVD events. This " omic" approach recently resulted in new targets for reducing CVD events. (C) 2014 by the American College of Cardiology Foundation.
引用
收藏
页码:2525 / 2540
页数:16
相关论文
共 50 条
  • [31] The clinical case for triglyceride-rich lipoproteins
    Thompson, GR
    ATHEROSCLEROSIS XI, 1998, 1155 : 599 - 603
  • [32] TRIGLYCERIDE-RICH LIPOPROTEINS: THEIR ROLE IN ATHEROSCLEROSIS
    Castillo-Nunez, Yulino
    Morales-Villegas, Enrique
    Aguilar-Salinas, Carlos A.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2022, 74 (02): : 61 - 70
  • [33] TRIGLYCERIDE-RICH LIPOPROTEINS AND ATHEROSCLEROSIS, FROM FAST TO FEAST
    STEINER, G
    ANNALS OF MEDICINE, 1993, 25 (05) : 431 - 435
  • [34] TRIGLYCERIDE RICH LIPOPROTEINS AND RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE IN DIFFERENT EUROPEAN POPULATIONS
    RUBBA, P
    DESIMONE, B
    PAUCIULLO, P
    KLINISCHE WOCHENSCHRIFT, 1990, 68 : 59 - 62
  • [35] Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis
    Schwartz, Eric A.
    Reaven, Peter D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (05): : 858 - 866
  • [36] Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Cellular aspects
    Gianturco, SH
    Bradley, WA
    CLINICAL CARDIOLOGY, 1999, 22 (06) : II7 - II14
  • [37] Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
    Ginsberg, Henry N.
    Packard, Chris J.
    Chapman, M. John
    Boren, Jan
    Aguilar-Salinas, Carlos A.
    Averna, Maurizio
    Ference, Brian A.
    Gaudet, Daniel
    Hegele, Robert A.
    Kersten, Sander
    Lewis, Gary F.
    Lichtenstein, Alice H.
    Moulin, Philippe
    Nordestgaard, Borge G.
    Remaley, Alan T.
    Staels, Bart
    Stroes, Erik S. G.
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale S.
    Tybjaerg-Hansen, Anne
    Stock, Jane K.
    Catapano, Alberico L.
    EUROPEAN HEART JOURNAL, 2021, 42 (47) : 4791 - +
  • [38] Triglyceride-Rich Lipoproteins and Plasma Lipid Transport
    Havel, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (01) : 9 - 19
  • [39] Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD
    Lamprea-Montealegre, Julio Alejandro
    Staplin, Natalie
    Herrington, William G.
    Haynes, Richard
    Emberson, Jonathan
    Baigent, Colin
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (01): : 47 - 60